Efficacy and safety of early enteral and intravenous fluid resuscitation in severe acute pancreatitis: a systematic review and meta-analysis.

Objective: To compare the efficacy and safety of enteral fluid resuscitation (via nasointestinal tube or colorectal tube) and intravenous fluid resuscitation (via intravenous route) in the early treatment of severe acute pancreatitis. Methods: In this study, 8 electronic databases (PubMed, Web of Science, Embase, Cochrane Library, Scopus, China HowNet database, Wanfang database, and VIP database) were searched to collect clinical studies from inception to June 12, 2022. After the quality evaluation and data extraction of the included studies, the RevMan 5.3 software was used for analysis. Results: A total of seven studies including 580 patients were studied in this meta-analysis, in which 291 cases were treated with enteral fluid resuscitation and 289 cases were treated with intravenous fluid resuscitation. Compared with the intravenous route group, the enteral route resuscitation group reduced the incidence of new organ failure (OR = 0.23, 95% CI: 0.12–0.43, P < 0.00001), the incidence of persistent organ failure (OR = 0.38, 95% CI: 0.22–0.64, P = 0.0003), the incidence of mechanical ventilation (OR = 0.15, 95% CI: 0.03–0.69, P = 0.01), the incidence of ICU care (OR = 0.49, 95% CI: 0.27–0.88, P = 0.02), and the incidence of pancreatic infection (OR = 0.38, 95% CI: 0.17–0.83, P = 0.02). There were no statistically significant differences in mortality (OR = 0.77, 95% CI: 0.35–1.66, P = 0.50), surgical intervention rate (OR = 0.47, 95% CI: 0.19–1.18, P = 0.11), and incidence of localized ascites (OR = 0.65, 95% CI: 0.25–1.73, P = 0.39). Conclusion: Early enteral fluid resuscitation is safe and effective for in severe pancreatitis. But this conclusion needs to be verified by more additional multi-centre randomized controlled trials with large samples. [ABSTRACT FROM AUTHOR]